Weight-loss

February 19, 2025 4:45 PM

Fat, not muscle: drugmakers in race for next weight-loss breakthrough

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the risk of falls and decrease overall strength, which could be especially harmful for older patients. The following companies are developing weight-loss treatments that help preserve or grow muscles while patients shed pounds: Eli Lilly The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versan...

September 16, 2024 5:19 PM

Study finds financial incentives boost weight loss in obese teens

A new study published in JAMA Pediatrics suggests that combining meal-replacement therapy with financial incentives can lead to greater weight loss in adolescents with severe obesity. Researchers, including Dr. Justin Ryder from Ann & Robert H. Lurie Children's Hospital of Chicago, found that teens who received both meal-replacement therapy and monetary rewards for weight loss achieved a higher reduction in body mass index (BMI) compared to those who only received meal-replacement therapy. ...

July 11, 2024 7:32 PM

Pfizer moves forward with once-daily weight-loss pill

Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under development by companies including Eli Lilly and Novo Nordisk that will offer patients a more convenient alternative to injections. Some analysts expect the weight-loss drug market, currently dominated ...